Safety Study of Elotuzumab in Combination With Thalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

Update Il y a 4 ans
Reference: NCT01632150

Woman and Man

  • | Country :
  • Spain
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of this study is to determine the safety and tolerability of elotuzumab administered in combination with thalidomide and dexamethasone in the treatment of relapsed and/or refractory multiple myeloma.


Inclusion criteria

  • Relapsed and/or Refractory Multiple Myeloma

Links